Regional differences and metabolic changes in normal aging of the human brain: proton MR spectroscopic imaging study.

BACKGROUND AND PURPOSE Aging is recognized to originate from a diversity of mechanisms that blur the limits between normal and pathologic processes. The purpose of this study was to determine the early effect of normal aging on the regional distribution of brain metabolite concentrations, including N-acetylaspartate (NAA), a major neuronal marker, choline (Cho), and creatine (Cr). METHODS Thirty-two healthy participants, ages 21 to 61 years, were examined by proton MR spectroscopic (1H MRS) imaging. 1H MRS imaging acquisitions were performed in two brain locations: the centrum semiovale and the temporal lobe. Thirty voxels were selected in four cerebral regions, cortical, semioval, temporal, and hippocampal, and 1H MR spectra were processed to determine the metabolite ratios. RESULTS With advancing age of the participants, the ratios of %NAA, NAA:Cho, and NAA:Cr were significantly decreased, whereas the ratios of %Cho and %Cr were significantly increased in the cortical, semioval, and temporal regions. On the basis of the significant metabolic difference determined by cluster analysis, two groups of 16 participants with ages ranging from 21 to 39 years (younger group) and 40 to 61 years (older group) were compared. Repeated measures analysis of variance tests, with multiple comparison procedures between the two age groups and among the four brain region groups, showed significant decreases of the %NAA, NAA:Cho, and NAA:Cr ratios in the semioval and temporal regions of the older group compared with the younger group. When compared with other cerebral regions, %NAA and %Cho ratios were significantly decreased in the hippocampal and cortical regions, respectively. CONCLUSION These metabolic changes suggest that brain aging is characterized by a reduction in neuronal viability or function associated with an accelerated membrane degradation and/or an increase in glial cell numbers.

[1]  B. Sykes,et al.  Water Eliminated Fourier Transform NMR Spectroscopy , 1972 .

[2]  D. Gadian,et al.  Magnetic resonance spectroscopy in temporal lobe epilepsy , 1994, Neurology.

[3]  D. Louis Collins,et al.  Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy , 1996, Nature Medicine.

[4]  Peter Boesiger,et al.  Quantitative 1H MRS of the human brain in vivo based on the simulation phantom calibration strategy , 1998, Magnetic resonance in medicine.

[5]  R. Kikinis,et al.  Age-related changes in intracranial compartment volumes in normal adults assessed by magnetic resonance imaging. , 1996, Journal of neurosurgery.

[6]  G. Fein,et al.  Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging , 1994, Annals of neurology.

[7]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  G. Matson,et al.  Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging , 1993, Annals of neurology.

[9]  Julius T. Tou,et al.  Pattern Recognition Principles , 1974 .

[10]  James Feeney,et al.  Data shift accumulation and alternate delay accumulation techniques for overcoming the dynamic range problem , 1980 .

[11]  Jullie W Pan,et al.  Quantitative spectroscopic imaging of the human brain , 1998, Magnetic resonance in medicine.

[12]  D. Head,et al.  Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. , 1997, Cerebral cortex.

[13]  J. Meyer,et al.  Cerebral circulation in the elderly. , 1993, Cerebrovascular and brain metabolism reviews.

[14]  Jeff H. Duyn,et al.  Transsynaptic Reduction in N‐Acetyl‐Aspartate in Cerebellar Diaschisis: A Proton MR Spectroscopic Imaging Study , 1994, Journal of computer assisted tomography.

[15]  G. Šimić,et al.  Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease , 1997, The Journal of comparative neurology.

[16]  O Almkvist,et al.  White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. , 1992, Archives of neurology.

[17]  A. Alavi,et al.  Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  T. Shirao,et al.  Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.

[19]  V. Haughton,et al.  Neuropsychological test findings in subjects with leukoaraiosis. , 1989, Archives of neurology.

[20]  K O Lim,et al.  Decreased gray matter in normal aging: an in vivo magnetic resonance study. , 1992, Journal of gerontology.

[21]  J. Vion-Dury,et al.  Localized brain proton MRS metabolic patterns in HIV-related encephalopathies. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[22]  J. Frahm,et al.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.

[23]  J. Trojanowski,et al.  Human fetal hippocampal development: I. Cytoarchitecture, myeloarchitecture, and neuronal morphologic features , 1996, The Journal of comparative neurology.

[24]  K. Krishnan,et al.  Proton spectroscopy of human brain: Effects of age and sex , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[25]  Shi-Jiang Li,et al.  Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy , 1998, Magnetic resonance in medicine.

[26]  P. Narayana,et al.  Relative Concentrations of Proton MR Visible Neurochemicals in Gray and White Matter in Human Brain , 1995, Magnetic resonance in medicine.

[27]  H. Larsson,et al.  The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium. , 1993, Magnetic resonance imaging.

[28]  Roland Kreis,et al.  Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy , 1993, Magnetic resonance in medicine.

[29]  D. Graham,et al.  Aging‐associated Changes in Human Brain , 1997, Journal of neuropathology and experimental neurology.

[30]  G. Fein,et al.  Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease , 1997, Neurology.

[31]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[32]  J. Frahm,et al.  Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS , 1998, Magnetic resonance in medicine.

[33]  George Fein,et al.  Proton magnetic resonance spectroscopy of human brain: Applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities , 1992, Magnetic resonance in medicine.

[34]  K. Double,et al.  Topography of brain atrophy during normal aging and alzheimer's disease , 1996, Neurobiology of Aging.

[35]  G Tedeschi,et al.  Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging , 1995, Neurology.

[36]  B. Miller A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.

[37]  Gioacchino Tedeschi,et al.  MR image segmentation and tissue metabolite contrast in 1H spectroscopic imaging of normal and aging brain , 1999, Magnetic resonance in medicine.

[38]  G. Fein,et al.  H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia. , 1995, Radiology.

[39]  R. Lesser,et al.  Proton MR spectroscopy in patients with seizure disorders. , 1994, AJNR. American journal of neuroradiology.

[40]  R. DeTeresa,et al.  Neocortical cell counts in normal human adult aging , 1987, Annals of neurology.

[41]  Richard S. J. Frackowiak,et al.  Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. , 1990, Brain : a journal of neurology.

[42]  K O Lim,et al.  In vivo spectroscopic quantification of the N‐acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging , 1999, Magnetic resonance in medicine.

[43]  J R Griffiths,et al.  Aging of the adult human brain: In vivo quantitation of metabolite content with proton magnetic resonance spectroscopy , 1999, Journal of magnetic resonance imaging : JMRI.

[44]  D Comar,et al.  Regional Cerebral Blood Flow and Oxygen Consumption in Human Aging , 1984, Stroke.

[45]  R. Kikinis,et al.  White matter changes with normal aging , 1998, Neurology.

[46]  T. Ernst,et al.  Abnormal cerebral metabolite concentrations in patients with probable alzheimer disease , 1994, Magnetic resonance in medicine.

[47]  J. Neale,et al.  Immunohistochemical localization of N-acetylaspartate in rat brain. , 1991, Neuroreport.

[48]  H. Blumenthal,et al.  Dementia of the Aged: Disease or Atypical‐Accelerated Aging? Biopathological and Psychological Perspectives , 1992, Journal of the American Geriatrics Society.

[49]  D J Jenden,et al.  In vivo proton magnetic resonance spectroscopy of the normal aging human brain. , 1996, Life sciences.

[50]  L Symon,et al.  Investigation into the Role of N‐Acetylaspartate in Cerebral Osmoregulation , 1995, Journal of neurochemistry.

[51]  C. Segebarth,et al.  Quantitative 31P MRS of the normal adult human brain. Assessment of interindividual differences and ageing effects , 1993, NMR in biomedicine.

[52]  P M Matthews,et al.  Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.

[53]  Jullie W Pan,et al.  Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T , 1994, Magnetic resonance in medicine.

[54]  William H. Oldendorf,et al.  N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain , 1989, Neuroscience & Biobehavioral Reviews.

[55]  Jens Frahm,et al.  Localized proton MRS of the human hippocampus: Metabolite concentrations and relaxation times , 1999, Magnetic resonance in medicine.

[56]  K. Lim,et al.  Estimating NAA in cortical gray matter with applications for measuring changes due to aging , 1997, Magnetic resonance in medicine.

[57]  A. Blamire,et al.  Early Temporal Variation of Cerebral Metabolites After Human Stroke: A Proton Magnetic Resonance Spectroscopy Study , 1993, Stroke.

[58]  J. Duyn,et al.  Quantitative proton MR spectroscopic imaging of the human brain , 1996, Magnetic resonance in medicine.

[59]  K. Takenouchi,et al.  Metabolite changes with age measured by proton magnetic resonance spectroscopy in normal subjects , 1997 .

[60]  Daniel H. Mathalon,et al.  Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus , 1995, Neurobiology of Aging.